Toll‐like receptor‐2 in cardiomyocytes and macrophages mediates isoproterenol‐induced cardiac inflammation and remodeling
The FASEB Journal · 2023
DOI: 10.1096/fj.202201345r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Jinfu Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Heart Failure. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Heart failure (HF) is the leading cause of morbidity and mortality worldwide. Activation of the innate immune system initiates an inflammatory response during cardiac remodeling induced by isoproterenol (ISO). Here, we investigated whether Toll‐like receptor‐2 (TLR2) mediates ISO‐induced inflammation, hypertrophy, and fibrosis. TLR2 was found to be increased in the heart tissues of mouse with HF under ISO challenge. Further, cardiomyocytes and macrophages were identified as the main cellular sources of the increased TLR2 levels in the model under ISO stimulation. The effect of TLR2 deficiency on ISO‐induced cardiac remodeling was determined using TLR2 knockout mice and bone marrow transplantation models. In vitro studies involving ISO‐treated cultured cardiomyocytes and macrophages showed that TLR2 knockdown significantly decreased ISO‐induced cell inflammation and remodeling via MAPKs/NF‐κB signaling. Mechanistically, ISO significantly increased the TLR2‐MyD88 interaction in the above cells in a TLR1‐dependent manner. Finally, DAMPs, such as HSP70 and fibronectin 1 (FN1), were found to be released from the cells under ISO stimulation, which further activated TLR1/2‐Myd88 signaling and subsequently activated pro‐inflammatory cytokine expression and cardiac remodeling. In summary, our findings suggest that TLR2 may be a target for the alleviation of chronic adrenergic stimulation‐associated HF. In addition, this paper points out the possibility of TLR2 as a new target for heart failure under ISO stimulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, China.
- Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qian, J., Liang, S., Wang, Q., Xu, J., Huang, W., Wu, G., & Liang, G. (2023). Toll‐like receptor‐2 in cardiomyocytes and macrophages mediates isoproterenol‐induced cardiac inflammation and remodeling. The FASEB Journal. https://doi.org/10.1096/fj.202201345r
Vancouver
Qian J, Liang S, Wang Q, Xu J, Huang W, Wu G, et al. Toll‐like receptor‐2 in cardiomyocytes and macrophages mediates isoproterenol‐induced cardiac inflammation and remodeling. The FASEB Journal. 2023. doi:10.1096/fj.202201345r
BibTeX
@article{Qian2023,
author = {Qian, Jinfu and Liang, Shiqi and Wang, Qinyan and Xu, Jiachen and Huang, Weijian and Wu, Gaojun and Liang, Guang},
title = {Toll‐like receptor‐2 in cardiomyocytes and macrophages mediates isoproterenol‐induced cardiac inflammation and remodeling},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202201345r}
}
EUVIMED